Brain Invasion in Meningioma—A Prognostic Potential Worth Exploring
Abstract
:Simple Summary
Abstract
1. Introduction
2. Histopathological Assessment of Invasive Growth
3. Imaging Aspects of Invasive Growth
4. Intraoperative Assessment and the Sampling Dilemma
5. Outlook
6. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Ostrom, Q.T.; Patil, N.; Cioffi, G.; Waite, K.; Kruchko, C.; Barnholtz-Sloan, J.S. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013–2017. Neuro Oncol. 2020, 22 (Suppl. S2), iv1–iv96. [Google Scholar] [CrossRef] [PubMed]
- Spasic, M.; Pelargos, P.E.; Barnette, N.; Bhatt, N.S.; Lee, S.J.; Ung, N.; Gopen, Q.; Yang, I. Incidental Meningiomas: Management in the Neuroimaging Era. Neurosurg. Clin. N. Am. 2016, 27, 229–238. [Google Scholar] [CrossRef]
- Louis, D.N.; Perry, A.; Reifenberger, G.; von Deimling, A.; Figarella-Branger, D.; Cavenee, W.K.; Ohgaki, H.; Wiestler, O.D.; Kleihues, P.; Ellison, D.W. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: A summary. Acta Neuropathol. 2016, 131, 803–820. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Goldbrunner, R.; Minniti, G.; Preusser, M.; Jenkinson, M.D.; Sallabanda, K.; Houdart, E.; von Deimling, A.; Stavrinou, P.; Lefranc, F.; Lund-Johansen, M.; et al. EANO guidelines for the diagnosis and treatment of meningiomas. Lancet. Oncol. 2016, 17, e383–e391. [Google Scholar] [CrossRef] [Green Version]
- Li, D.; Jiang, P.; Xu, S.; Li, C.; Xi, S.; Zhang, J.; Chen, Y.; Jiang, X.; Zhang, X.; Sai, K.; et al. Survival impacts of extent of resection and adjuvant radiotherapy for the modern management of high-grade meningiomas. J. Neurooncol. 2019, 145, 125–134. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nguyen, E.K.; Nguyen, T.K.; Boldt, G.; Louie, A.V.; Bauman, G.S. Hypofractionated stereotactic radiotherapy for intracranial meningioma: A systematic review. Neurooncol. Pract. 2019, 6, 346–353. [Google Scholar] [CrossRef] [PubMed]
- Weber, D.C.; Ares, C.; Villa, S.; Peerdeman, S.M.; Renard, L.; Baumert, B.G.; Lucas, A.; Veninga, T.; Pica, A.; Jefferies, S.; et al. Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042). Radiother. Oncol. 2018, 128, 260–265. [Google Scholar] [CrossRef] [Green Version]
- Wilson, T.A.; Huang, L.; Ramanathan, D.; Lopez-Gonzalez, M.; Pillai, P.; De Los Reyes, K.; Kumal, M.; Boling, W. Review of Atypical and Anaplastic Meningiomas: Classification, Molecular Biology, and Management. Front. Oncol. 2020, 10, 565582. [Google Scholar] [CrossRef]
- Harmanci, A.S.; Youngblood, M.W.; Clark, V.E.; Coskun, S.; Henegariu, O.; Duran, D.; Erson-Omay, E.Z.; Kaulen, L.D.; Lee, T.I.; Abraham, B.J.; et al. Integrated genomic analyses of de novo pathways underlying atypical meningiomas. Nat. Commun. 2017, 8, 14433. [Google Scholar] [CrossRef]
- Clark, V.E.; Erson-Omay, E.Z.; Serin, A.; Yin, J.; Cotney, J.; Ozduman, K.; Avsar, T.; Li, J.; Murray, P.B.; Henegariu, O.; et al. Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science 2013, 339, 1077–1080. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Behling, F.; Fodi, C.; Gepfner-Tuma, I.; Kaltenbach, K.; Renovanz, M.; Paulsen, F.; Skardelly, M.; Honegger, J.; Tatagiba, M.; International Consortium on Meningiomas; et al. H3K27me3 loss indicates an increased risk of recurrence in the Tubingen meningioma cohort. Neuro Oncol. 2020. [Google Scholar] [CrossRef] [PubMed]
- Katz, L.M.; Hielscher, T.; Liechty, B.; Silverman, J.; Zagzag, D.; Sen, R.; Wu, P.; Golfinos, J.G.; Reuss, D.; Neidert, M.C.; et al. Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence. Acta Neuropathol. 2018, 135, 955–963. [Google Scholar] [CrossRef] [Green Version]
- Sahm, F.; Schrimpf, D.; Olar, A.; Koelsche, C.; Reuss, D.; Bissel, J.; Kratz, A.; Capper, D.; Schefzyk, S.; Hielscher, T.; et al. TERT Promoter Mutations and Risk of Recurrence in Meningioma. J. Natl. Cancer Inst. 2016, 108. [Google Scholar] [CrossRef] [PubMed]
- Sievers, P.; Hielscher, T.; Schrimpf, D.; Stichel, D.; Reuss, D.E.; Berghoff, A.S.; Neidert, M.C.; Wirsching, H.G.; Mawrin, C.; Ketter, R.; et al. CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas. Acta Neuropathol. 2020, 140, 409–413. [Google Scholar] [CrossRef]
- Qin, C.; Huang, M.; Pan, Y.; Li, Y.; Long, W.; Liu, Q. Brain-invasive meningiomas: Molecular mechanisms and potential therapeutic options. Brain Tumor. Pathol. 2021. [Google Scholar] [CrossRef] [PubMed]
- Pecina-Slaus, N.; Kafka, A.; Lechpammer, M. Molecular Genetics of Intracranial Meningiomas with Emphasis on Canonical Wnt Signalling. Cancers 2016, 8, 67. [Google Scholar] [CrossRef] [Green Version]
- Brunner, E.C.; Romeike, B.F.; Jung, M.; Comtesse, N.; Meese, E. Altered expression of beta-catenin/E-cadherin in meningiomas. Histopathology 2006, 49, 178–187. [Google Scholar] [CrossRef] [PubMed]
- Bukovac, A.; Kafka, A.; Raguz, M.; Brlek, P.; Dragicevic, K.; Muller, D.; Pecina-Slaus, N. Are We Benign? What Can Wnt Signaling Pathway and Epithelial to Mesenchymal Transition Tell Us about Intracranial Meningioma Progression. Cancers 2021, 13, 1633. [Google Scholar] [CrossRef]
- Baumgarten, P.; Gessler, F.; Schittenhelm, J.; Skardelly, M.; Tews, D.S.; Senft, C.; Dunst, M.; Imoehl, L.; Plate, K.H.; Wagner, M.; et al. Brain invasion in otherwise benign meningiomas does not predict tumor recurrence. Acta Neuropathol. 2016, 132, 479–481. [Google Scholar] [CrossRef]
- Biczok, A.; Jungk, C.; Egensperger, R.; von Deimling, A.; Suchorska, B.; Tonn, J.C.; Herold-Mende, C.; Schichor, C. Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome. J. Neurooncol. 2019, 145, 469–477. [Google Scholar] [CrossRef]
- Nakasu, S.; Nakasu, Y. Prognostic significance of brain invasion in meningiomas: Systematic review and meta-analysis. Brain Tumor. Pathol. 2021, 38, 81–95. [Google Scholar] [CrossRef] [PubMed]
- Perry, A.; Stafford, S.L.; Scheithauer, B.W.; Suman, V.J.; Lohse, C.M. Meningioma grading: An analysis of histologic parameters. Am. J. Surg. Pathol. 1997, 21, 1455–1465. [Google Scholar] [CrossRef]
- Louis, D.N.; Ohgaki, H.; Wiestler, O.D.; Cavenee, W.K.; Burger, P.C.; Jouvet, A.; Scheithauer, B.W.; Kleihues, P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007, 114, 97–109. [Google Scholar] [CrossRef] [Green Version]
- Kleihues, P.; Louis, D.N.; Scheithauer, B.W.; Rorke, L.B.; Reifenberger, G.; Burger, P.C.; Cavenee, W.K. The WHO classification of tumors of the nervous system. J. Neuropathol. Exp. Neurol. 2002, 61, 215–225, discussion 226–219. [Google Scholar] [CrossRef]
- Kleihues, P.; Burger, P.C.; Scheithauer, B.W. The new WHO classification of brain tumours. Brain Pathol. 1993, 3, 255–268. [Google Scholar] [CrossRef]
- McLean, C.A.; Jolley, D.; Cukier, E.; Giles, G.; Gonzales, M.F. Atypical and malignant meningiomas: Importance of micronecrosis as a prognostic indicator. Histopathology 1993, 23, 349–353. [Google Scholar] [CrossRef]
- Perry, A.; Scheithauer, B.W.; Stafford, S.L.; Lohse, C.M.; Wollan, P.C. “Malignancy” in meningiomas: A clinicopathologic study of 116 patients, with grading implications. Cancer 1999, 85, 2046–2056. [Google Scholar] [CrossRef]
- Perry, A. The definition and role of brain invasion in meningioma grading: Still controversial after all these years. Free Neuropathol. 2021, 2, 1–6. [Google Scholar] [CrossRef]
- Rogers, C.L.; Perry, A.; Pugh, S.; Vogelbaum, M.A.; Brachman, D.; McMillan, W.; Jenrette, J.; Barani, I.; Shrieve, D.; Sloan, A.; et al. Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539. Neuro Oncol. 2016, 18, 565–574. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Vranic, A.; Popovic, M.; Cör, A.; Prestor, B.; Pizem, J. Mitotic count, brain invasion, and location are independent predictors of recurrence-free survival in primary atypical and malignant meningiomas: A study of 86 patients. Neurosurgery 2010, 67, 1124–1132. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Champeaux, C.; Wilson, E.; Shieff, C.; Khan, A.A.; Thorne, L. WHO grade II meningioma: A retrospective study for outcome and prognostic factor assessment. J. Neurooncol. 2016, 129, 337–345. [Google Scholar] [CrossRef] [PubMed]
- Streckert, E.M.S.; Hess, K.; Sporns, P.B.; Adeli, A.; Brokinkel, C.; Kriz, J.; Holling, M.; Eich, H.T.; Paulus, W.; Spille, D.C.; et al. Clinical, radiological, and histopathological predictors for long-term prognosis after surgery for atypical meningiomas. Acta Neurochir. 2019, 161, 1647–1656. [Google Scholar] [CrossRef]
- Pizem, J.; Velnar, T.; Prestor, B.; Mlakar, J.; Popovic, M. Brain invasion assessability in meningiomas is related to meningioma size and grade, and can be improved by extensive sampling of the surgically removed meningioma specimen. Clin. Neuropathol. 2014, 33, 354–363. [Google Scholar] [CrossRef]
- Spille, D.C.; Heß, K.; Sauerland, C.; Sanai, N.; Stummer, W.; Paulus, W.; Brokinkel, B. Brain Invasion in Meningiomas: Incidence and Correlations with Clinical Variables and Prognosis. World Neurosurg. 2016, 93, 346–354. [Google Scholar] [CrossRef] [PubMed]
- Zima, L.; Baine, M.J.; Sleightholm, R.; Wang, B.; Punsoni, M.; Aizenberg, M.; Zhang, C. Pathologic Characteristics Associated with Local Recurrence of Atypical Meningiomas Following Surgical Resection. J. Clin. Med. Res. 2021, 13, 143–150. [Google Scholar] [CrossRef] [PubMed]
- Biczok, A.; Karschnia, P.; Vitalini, R.; Lenski, M.; Greve, T.; Thorsteinsdottir, J.; Egensperger, R.; Dorn, F.; Tonn, J.C.; Schichor, C. Past medical history of tumors other than meningioma is a negative prognostic factor for tumor recurrence in meningiomas WHO grade I. Acta Neurochir. 2021. [Google Scholar] [CrossRef]
- Fioravanzo, A.; Caffo, M.; Di Bonaventura, R.; Gardiman, M.P.; Ghimenton, C.; Ius, T.; Maffeis, V.; Martini, M.; Nicolato, A.; Pallini, R.; et al. A Risk Score Based on 5 Clinico-Pathological Variables Predicts Recurrence of Atypical Meningiomas. J. Neuropathol. Exp. Neurol. 2020, 79, 500–507. [Google Scholar] [CrossRef]
- Banan, R.; Abbetmeier-Basse, M.; Hong, B.; Dumitru, C.A.; Sahm, F.; Nakamura, M.; Krauss, J.K.; Hartmann, C. The prognostic significance of clinicopathological features in meningiomas: Microscopic brain invasion can predict patient outcome in otherwise benign meningiomas. Neuropathol. Appl. Neurobiol. 2021. [Google Scholar] [CrossRef] [PubMed]
- Backer-Grondahl, T.; Moen, B.H.; Arnli, M.B.; Torseth, K.; Torp, S.H. Immunohistochemical characterization of brain-invasive meningiomas. Int. J. Clin. Exp. Pathol. 2014, 7, 7206–7219. [Google Scholar]
- Zeltner, L.; Schittenhelm, J.; Mittelbronn, M.; Roser, F.; Tatagiba, M.; Mawrin, C.; Kim, Y.J.; Bornemann, A. The astrocytic response towards invasive meningiomas. Neuropathol. Appl. Neurobiol. 2007, 33, 163–168. [Google Scholar] [CrossRef]
- Adeli, A.; Hess, K.; Mawrin, C.; Streckert, E.M.S.; Stummer, W.; Paulus, W.; Kemmling, A.; Holling, M.; Heindel, W.; Schmidt, R.; et al. Prediction of brain invasion in patients with meningiomas using preoperative magnetic resonance imaging. Oncotarget 2018, 9, 35974–35982. [Google Scholar] [CrossRef] [Green Version]
- Joo, L.; Park, J.E.; Park, S.Y.; Nam, S.J.; Kim, Y.H.; Kim, J.H.; Kim, H.S. Extensive peritumoral edema and brain-to-tumor interface MRI features enable prediction of brain invasion in meningioma: Development and validation. Neuro Oncol. 2021, 23, 324–333. [Google Scholar] [CrossRef] [PubMed]
- Ong, T.; Bharatha, A.; Alsufayan, R.; Das, S.; Lin, A.W. MRI predictors for brain invasion in meningiomas. Neuroradiol. J. 2021, 34, 3–7. [Google Scholar] [CrossRef]
- Simis, A.; de Aguiar, P.H.P.; Leite, C.C.; Santana, P.A., Jr.; Rosemberg, S.; Teixeira, M.J. Peritumoral brain edema in benign meningiomas: Correlation with clinical, radiologic, and surgical factors and possible role on recurrence. Surg. Neurol. 2008, 70, 471–477, discussion 477. [Google Scholar] [CrossRef]
- Ko, C.C.; Zhang, Y.; Chen, J.H.; Chang, K.T.; Chen, T.Y.; Lim, S.W.; Wu, T.C.; Su, M.Y. Pre-operative MRI Radiomics for the Prediction of Progression and Recurrence in Meningiomas. Front. Neurol. 2021, 12, 636235. [Google Scholar] [CrossRef]
- Kandemirli, S.G.; Chopra, S.; Priya, S.; Ward, C.; Locke, T.; Soni, N.; Srivastava, S.; Jones, K.; Bathla, G. Presurgical detection of brain invasion status in meningiomas based on first-order histogram based texture analysis of contrast enhanced imaging. Clin. Neurol. Neurosurg. 2020, 198, 106205. [Google Scholar] [CrossRef] [PubMed]
- Zhang, J.; Sun, J.; Han, T.; Zhao, Z.; Cao, Y.; Zhang, G.; Zhou, J. Radiomic features of magnetic resonance images as novel preoperative predictive factors of bone invasion in meningiomas. Eur. J. Radiol. 2020, 132, 109287. [Google Scholar] [CrossRef] [PubMed]
- Behling, F.; Fodi, C.; Gepfner-Tuma, I.; Machetanz, K.; Renovanz, M.; Skardelly, M.; Bornemann, A.; Honegger, J.; Tabatabai, G.; Tatagiba, M.; et al. CNS Invasion in Meningioma-How the Intraoperative Assessment Can Improve the Prognostic Evaluation of Tumor Recurrence. Cancers 2020, 12, 3620. [Google Scholar] [CrossRef] [PubMed]
- Andrews, R.J.; Bringas, J.R. A review of brain retraction and recommendations for minimizing intraoperative brain injury. Neurosurgery 1993, 33, 1052–1063, discussion 1063–1054. [Google Scholar] [CrossRef] [PubMed]
- Banu, M.A.; Mehta, A.; Ottenhausen, M.; Fraser, J.F.; Patel, K.S.; Szentirmai, O.; Anand, V.K.; Tsiouris, A.J.; Schwartz, T.H. Endoscope-assisted endonasal versus supraorbital keyhole resection of olfactory groove meningiomas: Comparison and combination of 2 minimally invasive approaches. J. Neurosurg. 2016, 124, 605–620. [Google Scholar] [CrossRef] [Green Version]
- Borghei-Razavi, H.; Truong, H.Q.; Fernandes-Cabral, D.T.; Celtikci, E.; Chabot, J.D.; Stefko, S.T.; Wang, E.W.; Snyderman, C.H.; Cohen-Gadol, A.; Gardner, P.A.; et al. Minimally Invasive Approaches for Anterior Skull Base Meningiomas: Supraorbital Eyebrow, Endoscopic Endonasal, or a Combination of Both? Anatomic Study, Limitations, and Surgical Application. World Neurosurg. 2018, 112, e666–e674. [Google Scholar] [CrossRef] [PubMed]
- Raffa, G.; Picht, T.; Scibilia, A.; Rosler, J.; Rein, J.; Conti, A.; Ricciardo, G.; Cardali, S.M.; Vajkoczy, P.; Germano, A. Surgical treatment of meningiomas located in the rolandic area: The role of navigated transcranial magnetic stimulation for preoperative planning, surgical strategy, and prediction of arachnoidal cleavage and motor outcome. J. Neurosurg. 2019, 1–12. [Google Scholar] [CrossRef] [PubMed]
- Jenkinson, M.D.; Santarius, T.; Zadeh, G.; Aldape, K.D. Atypical meningioma-is it time to standardize surgical sampling techniques? Neuro Oncol. 2017, 19, 453–454. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rempel, S.A.; Ge, S.; Gutierrez, J.A. SPARC: A potential diagnostic marker of invasive meningiomas. Clin. Cancer Res. 1999, 5, 237–241. [Google Scholar] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Behling, F.; Hempel, J.-M.; Schittenhelm, J. Brain Invasion in Meningioma—A Prognostic Potential Worth Exploring. Cancers 2021, 13, 3259. https://doi.org/10.3390/cancers13133259
Behling F, Hempel J-M, Schittenhelm J. Brain Invasion in Meningioma—A Prognostic Potential Worth Exploring. Cancers. 2021; 13(13):3259. https://doi.org/10.3390/cancers13133259
Chicago/Turabian StyleBehling, Felix, Johann-Martin Hempel, and Jens Schittenhelm. 2021. "Brain Invasion in Meningioma—A Prognostic Potential Worth Exploring" Cancers 13, no. 13: 3259. https://doi.org/10.3390/cancers13133259